溫馨提示：需求數(shù)量不同，價(jià)格不同。請聯(lián)系我們，確認(rèn)當(dāng)前新的報(bào)價(jià)！
PanelPlex用于癌癥檢測、抗微生物耐藥性及其他應(yīng)用的多重PCR設(shè)計(jì)軟件。提供自動化的多重PCR（聚合酶鏈?zhǔn)椒磻?yīng)）設(shè)計(jì)，具有覆蓋率、靈敏度和特異性。
PanelPlex可以在幾個(gè)小時(shí)的很短的時(shí)間內(nèi)設(shè)計(jì)多達(dá)100個(gè)Plex，成功率為95%或更高。自動化PCR引物設(shè)計(jì)，對全部目標(biāo)進(jìn)行高度均勻的擴(kuò)增。也可以在面板存在的情況下進(jìn)行設(shè)計(jì)。
PanelPlex通過解決以下問題解決了這些問題：
PanelPlex節(jié)省了數(shù)月（平均6-9個(gè)月）的迭代實(shí)驗(yàn)試錯優(yōu)化時(shí)間。
產(chǎn)生診斷質(zhì)量設(shè)計(jì)。
DNA或RNA靶標(biāo)的多種變體的自動化共識設(shè)計(jì)。
PanelPlex使用ThermoBLAST“播放列表”來掃描導(dǎo)致假陽性測試的脫靶雜交。
通過擴(kuò)展您的多重PCR分析設(shè)計(jì)流程來增加您的業(yè)務(wù)—進(jìn)行更多的分析、更快的上市時(shí)間和更高的效率。
圍繞各種潛在工件進(jìn)行設(shè)計(jì)。
PanelPlex可自動設(shè)計(jì)用于腫瘤學(xué)和其他應(yīng)用的基因組富集多路復(fù)用面板。全部目標(biāo)的高度均勻擴(kuò)增。
考慮設(shè)計(jì)周期
多路復(fù)用面板設(shè)計(jì)的常見挑戰(zhàn)包括冗長且昂貴的設(shè)計(jì)周期。這通常是組織內(nèi)部知識差距以及軟件和次優(yōu)設(shè)計(jì)工具的結(jié)果。我們經(jīng)常看到研究人員依賴過時(shí)的工具。如果分析設(shè)計(jì)對您的組織很關(guān)鍵，您為什么要使用次優(yōu)工具？
【英文介紹】
Multiplex PCR design software for cancer panels, anti microbial resistance, other and other applications.
Providing completely automated design of multiplex PCR (Polymerase chain reaction) with unprecedented coverage, sensitivity and specificity.
PanelPlex solves these problems by addressing the following:
PanelPlex saves several months (6-9 months on average) of iterative experimental trial-and-error optimization.
Produces diagnostic quality designs.
Automated consensus design of multiple variants of DNA or RNA targets.
PanelPlex uses ThermoBLAST "playlists" to scan for off-target hybridizations that cause false-positive tests.
Increase your business by scaling your multiplex PCR assay design process – make more assays, faster time to market, and with higher efficacy.
Designs around a wide variety of potential artifacts.
We think about the design cycle.
Common challenges in multiplex panel design include a lengthy and costly design cycle. This can often be the result of both a knowledge gap within the organization along with freeware and suboptimal design tools. We often see researchers relying on outdated, antiquated tools. If assay design is mission critical to your organization, why would you want to use a suboptimal tool?
